Your browser is no longer supported. Please, upgrade your browser.
ZTS [NYSE]
Zoetis Inc.
IndexS&P 500 P/E46.21 EPS (ttm)3.48 Insider Own0.08% Shs Outstand475.50M Perf Week-3.62%
Market Cap75.99B Forward P/E37.71 EPS next Y4.27 Insider Trans-28.46% Shs Float474.88M Perf Month0.92%
Income1.66B PEG4.66 EPS next Q0.87 Inst Own94.30% Short Float0.77% Perf Quarter-1.65%
Sales6.54B P/S11.62 EPS this Y9.60% Inst Trans-0.06% Short Ratio2.15 Perf Half Y12.61%
Book/sh7.58 P/B21.23 EPS next Y12.32% ROA13.30% Target Price185.00 Perf Year16.18%
Cash/sh- P/C- EPS next 5Y9.91% ROE55.20% 52W Range90.14 - 176.64 Perf YTD-2.74%
Dividend1.00 P/FCF65.57 EPS past 5Y21.80% ROI16.40% 52W High-8.54% Beta0.63
Dividend %0.62% Quick Ratio2.10 Sales past 5Y5.50% Gross Margin69.80% 52W Low79.23% ATR3.26
Employees10600 Current Ratio2.80 Sales Q/Q12.80% Oper. Margin30.80% RSI (14)45.49 Volatility2.25% 1.98%
OptionableYes Debt/Eq2.14 EPS Q/Q11.30% Profit Margin25.40% Rel Volume1.42 Prev Close160.96
ShortableYes LT Debt/Eq1.83 EarningsNov 05 BMO Payout21.80% Avg Volume1.70M Price161.56
Recom2.00 SMA20-1.32% SMA50-1.01% SMA2007.86% Volume2,414,665 Change0.37%
Sep-21-20Initiated Atlantic Equities Overweight $191
Aug-14-20Upgrade Edward Jones Hold → Buy
Aug-12-20Downgrade Gabelli & Co Buy → Hold
May-27-20Initiated Jefferies Buy $152
Jan-10-20Initiated Raymond James Mkt Perform
Sep-09-19Initiated Goldman Buy $145
Jul-01-19Downgrade BofA/Merrill Buy → Neutral $111 → $120
Jun-11-19Initiated Barclays Overweight $120
May-23-19Initiated Guggenheim Buy $114
May-03-19Downgrade Gabelli & Co Buy → Hold $108
Mar-20-19Initiated SunTrust Hold
Mar-04-19Upgrade Stifel Hold → Buy $97 → $110
Jan-23-19Initiated UBS Neutral $86
Oct-15-18Upgrade JP Morgan Neutral → Overweight
Aug-22-18Downgrade Stifel Buy → Hold $95
Aug-03-18Reiterated Stifel Buy $86 → $95
Apr-19-18Reiterated Citigroup Buy $85 → $98
Mar-19-18Downgrade Morgan Stanley Overweight → Equal-Weight
Feb-16-18Reiterated Stifel Buy $84 → $86
Jan-04-18Upgrade Citigroup Neutral → Buy
Jan-14-21 08:21AM  
Jan-12-21 11:40AM  
Dec-30-20 08:30AM  
Dec-24-20 06:54AM  
Dec-23-20 10:59AM  
Dec-18-20 08:30AM  
Dec-15-20 10:55AM  
Dec-09-20 04:30PM  
Dec-08-20 04:30PM  
Dec-07-20 10:21AM  
Dec-05-20 11:32AM  
Dec-01-20 03:48PM  
09:35AM  
Nov-16-20 08:00AM  
Nov-13-20 09:54AM  
09:42AM  
Nov-12-20 08:00AM  
Nov-09-20 02:52PM  
Nov-06-20 10:30PM  
04:35PM  
01:39PM  
09:59AM  
Nov-05-20 04:13PM  
11:38AM  
10:39AM  
08:58AM  
08:25AM  
07:00AM  
03:00AM  
Nov-04-20 08:42AM  
08:25AM  
Nov-03-20 10:40AM  
Nov-02-20 10:43AM  
Oct-30-20 12:57PM  
Oct-28-20 11:40AM  
Oct-26-20 02:08PM  
08:30AM  
Oct-23-20 04:06PM  
Oct-21-20 12:03PM  
Oct-16-20 11:30AM  
Oct-14-20 12:10PM  
09:01AM  
Oct-07-20 04:33PM  
Oct-05-20 11:40AM  
Sep-30-20 08:30AM  
Sep-23-20 02:10PM  
Sep-17-20 11:40AM  
Sep-15-20 08:00PM  
06:14PM  
10:40AM  
Sep-13-20 08:00PM  
Sep-11-20 09:04AM  
Sep-10-20 08:30AM  
Sep-08-20 07:04PM  
Sep-05-20 11:31AM  
Sep-04-20 04:28PM  
Sep-02-20 09:10AM  
Sep-01-20 11:40AM  
08:10AM  
Aug-31-20 01:25PM  
Aug-28-20 11:02AM  
Aug-21-20 03:51AM  
Aug-14-20 05:39PM  
Aug-13-20 03:04AM  
Aug-06-20 04:07PM  
11:31AM  
08:45AM  
07:00AM  
Jul-30-20 12:33PM  
Jul-21-20 12:10PM  
09:15AM  
Jul-18-20 08:09AM  
Jul-17-20 11:05AM  
Jul-10-20 08:06AM  
Jul-08-20 01:25PM  
Jul-07-20 07:06AM  
Jun-26-20 08:30AM  
Jun-08-20 10:41AM  
08:30AM  
Jun-05-20 11:32AM  
08:14AM  
Jun-03-20 10:00AM  
May-29-20 01:01PM  
May-26-20 03:20PM  
May-22-20 11:40AM  
May-20-20 04:30PM  
May-19-20 08:10PM  
May-18-20 08:30AM  
May-11-20 01:23PM  
May-07-20 08:45PM  
11:29AM  
May-06-20 04:23PM  
03:32PM  
01:56PM  
01:22PM  
11:23AM  
08:35AM  
07:00AM  
May-05-20 11:45AM  
May-04-20 01:36PM  
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites that include fleas, ticks, and worms. It also provides other pharmaceutical products, which comprise pain and sedation, antiemetic, reproductive, and oncology products; Dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives that offer medicines to livestock. In addition, the company offers portable blood and urine analysis systems, and point-of-care diagnostic products, including instruments and reagents, rapid immunoassay tests, reference laboratory kits, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision livestock farming. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chen Heidi C.Executive Vice PresidentDec 01Option Exercise41.831,18049,35917,515Dec 03 05:16 PM
Chen Heidi C.Executive Vice PresidentDec 01Sale161.641,180190,73516,335Dec 03 05:16 PM
PECK KRISTIN CChief Executive OfficerNov 25Option Exercise30.896,500200,78538,374Nov 25 04:42 PM
PECK KRISTIN CChief Executive OfficerNov 25Sale161.5110,5001,695,81027,874Nov 25 04:42 PM
Lagano RoxanneExecutive Vice PresidentNov 19Option Exercise41.836,000250,98041,680Nov 20 04:47 PM
Lagano RoxanneExecutive Vice PresidentNov 19Sale164.066,000984,36035,680Nov 20 04:47 PM
Alaix Juan RamonDirectorNov 13Sale165.4691,74715,180,5614,266Nov 17 04:30 PM
Chen Heidi C.Executive Vice PresidentNov 02Option Exercise41.831,17949,31817,514Nov 03 04:47 PM
Chen Heidi C.Executive Vice PresidentNov 02Sale161.431,179190,32616,335Nov 03 04:47 PM
Trawicki RomanExecutive Vice PresidentOct 01Option Exercise55.024,080224,4825,501Oct 02 06:08 PM
Chen Heidi C.Executive Vice PresidentOct 01Option Exercise41.831,17949,31817,514Oct 02 06:04 PM
Trawicki RomanExecutive Vice PresidentOct 01Sale166.035,501913,3530Oct 02 06:08 PM
Chen Heidi C.Executive Vice PresidentOct 01Sale166.231,179195,98516,335Oct 02 06:04 PM
Rhodes LindaDirectorSep 04Sale159.161,087173,0071,468Sep 08 04:18 PM
Chen Heidi C.Executive Vice PresidentSep 01Option Exercise41.831,17949,31817,514Sep 02 04:48 PM
Chen Heidi C.Executive Vice PresidentSep 01Sale160.711,179189,47716,335Sep 02 04:48 PM
PECK KRISTIN CChief Executive OfficerAug 25Option Exercise30.896,500200,78542,374Aug 26 06:00 PM
PECK KRISTIN CChief Executive OfficerAug 25Sale157.6110,5001,654,88931,874Aug 26 06:00 PM
Lagano RoxanneExecutive Vice PresidentAug 19Option Exercise41.836,000250,98041,680Aug 21 04:27 PM
Lagano RoxanneExecutive Vice PresidentAug 19Sale160.376,000962,22035,680Aug 21 04:27 PM
Knupp Catherine A.Executive Vice PresidentAug 13Sale158.8613,0002,065,16050,368Aug 17 04:26 PM
Reed Willie MDirectorAug 13Sale159.071,885299,8474,635Aug 17 04:23 PM
Chen Heidi C.Executive Vice PresidentAug 03Option Exercise41.831,17949,31817,514Aug 04 04:31 PM
Chen Heidi C.Executive Vice PresidentAug 03Sale152.191,179179,43216,335Aug 04 04:31 PM
Chen Heidi C.Executive Vice PresidentJul 01Option Exercise41.831,17949,31817,514Jul 02 06:13 PM
Trawicki RomanExecutive Vice PresidentJul 01Option Exercise55.024,079224,4276,920Jul 02 06:18 PM
Chen Heidi C.Executive Vice PresidentJul 01Sale137.291,179161,86516,335Jul 02 06:13 PM
Trawicki RomanExecutive Vice PresidentJul 01Sale137.295,499754,9581,421Jul 02 06:18 PM
Chen Heidi C.Executive Vice PresidentJun 01Option Exercise41.831,17949,31817,514Jun 02 04:18 PM
Chen Heidi C.Executive Vice PresidentJun 01Sale138.651,179163,46816,335Jun 02 04:18 PM
PECK KRISTIN CChief Executive OfficerMay 26Option Exercise27.976,500181,78746,374May 28 04:29 PM
PECK KRISTIN CChief Executive OfficerMay 26Sale131.3110,5001,378,78335,874May 28 04:29 PM
Lagano RoxanneExecutive Vice PresidentMay 19Option Exercise46.094,463205,70040,143May 21 04:19 PM
Lagano RoxanneExecutive Vice PresidentMay 19Sale131.024,463584,74235,680May 21 04:19 PM
Chen Heidi C.Executive Vice PresidentMay 01Option Exercise41.831,17949,31817,514May 04 04:49 PM
Chen Heidi C.Executive Vice PresidentMay 01Sale127.441,179150,25216,335May 04 04:49 PM
Trawicki RomanExecutive Vice PresidentApr 07Option Exercise55.024,079224,4278,340Apr 07 04:24 PM
Trawicki RomanExecutive Vice PresidentApr 07Sale130.005,499714,8702,841Apr 07 04:24 PM
Chen Heidi C.Executive Vice PresidentApr 06Option Exercise41.831,17949,31817,514Apr 07 04:21 PM
Chen Heidi C.Executive Vice PresidentApr 06Sale120.001,179141,48016,335Apr 07 04:21 PM
David GlennChief Financial OfficerMar 05Option Exercise53.8043,7782,355,17469,519Mar 06 05:19 PM
David GlennChief Financial OfficerMar 05Sale140.8943,7786,167,79425,741Mar 06 05:19 PM
Alaix Juan RamonDirectorMar 04Option Exercise52.12218,20811,372,091314,221Mar 05 04:26 PM
Alaix Juan RamonDirectorMar 04Sale141.38218,20830,850,45196,013Mar 05 04:26 PM
Alaix Juan RamonDirectorMar 03Option Exercise41.8345,4521,901,257141,465Mar 05 04:26 PM
Alaix Juan RamonDirectorMar 03Sale140.6645,4526,393,05996,013Mar 05 04:26 PM
Chen Heidi C.Executive Vice PresidentMar 02Option Exercise41.831,17949,31817,514Mar 03 04:35 PM
Chen Heidi C.Executive Vice PresidentMar 02Sale134.301,179158,34016,335Mar 03 04:35 PM
PECK KRISTIN CChief Executive OfficerFeb 25Option Exercise26.006,500169,00051,799Feb 26 04:22 PM
PECK KRISTIN CChief Executive OfficerFeb 25Sale138.1011,9251,646,78739,874Feb 26 04:22 PM
Alaix Juan RamonDirectorFeb 21Option Exercise42.76120,3535,145,906216,366Feb 24 04:14 PM
Alaix Juan RamonDirectorFeb 21Sale142.32120,35317,128,63996,013Feb 24 04:14 PM
Alaix Juan RamonDirectorFeb 20Option Exercise46.0920,725955,215116,738Feb 21 04:22 PM
Alaix Juan RamonDirectorFeb 20Sale143.6120,7252,976,31796,013Feb 21 04:22 PM
Lagano RoxanneExecutive Vice PresidentFeb 19Option Exercise46.094,463205,70040,143Feb 20 04:22 PM
Trawicki RomanExecutive Vice PresidentFeb 19Option Exercise55.024,079224,4279,760Feb 20 04:26 PM
Alaix Juan RamonDirectorFeb 19Option Exercise46.0963,0462,905,790159,059Feb 21 04:22 PM
Alaix Juan RamonDirectorFeb 19Sale144.0363,0469,080,57796,013Feb 21 04:22 PM
Lagano RoxanneExecutive Vice PresidentFeb 19Sale143.414,463640,03935,680Feb 20 04:22 PM
Trawicki RomanExecutive Vice PresidentFeb 19Sale143.425,499788,6674,261Feb 20 04:26 PM
Chen Heidi C.Executive Vice PresidentFeb 19Sale143.413,289471,67516,335Feb 20 04:18 PM
Chen Heidi C.Executive Vice PresidentFeb 03Option Exercise41.831,17949,31812,642Feb 04 06:07 PM
Chen Heidi C.Executive Vice PresidentFeb 03Sale134.581,179158,67011,463Feb 04 06:07 PM
Chen Heidi C.Executive Vice PresidentJan 21Option Exercise41.8315,329641,21226,792Jan 23 04:48 PM
Chen Heidi C.Executive Vice PresidentJan 21Sale139.8115,3292,143,11511,463Jan 23 04:48 PM